Traws Pharma, Inc. (TRAW): Total Liabilities
$11.25M
As of 2025-12-31
$9.78M
As of 2026-06-30
+0.5%
3-year compound annual growth
-4.0%
5-year compound annual growth
-1.1%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $11.25M | -80.1% | 2026-04-15, Balance as of period end |
| 2024-12-31 | $56.59M | +371.2% | 2026-04-15, Balance as of period end |
| 2023-12-31 | $12.01M | +8.6% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $11.06M | +18.2% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $9.36M | -32.2% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $13.81M | +14.1% | 2022-03-21, Balance as of period end |
| 2019-12-31 | $12.10M | -3.5% | 2021-03-18, Balance as of period end |
| 2018-12-31 | $12.54M | -20.9% | 2020-03-27, Balance as of period end |
| 2017-12-31 | $15.84M | -12.5% | 2019-04-01, Balance as of period end |
| 2016-12-31 | $18.11M | +43.6% | 2018-03-16, Balance as of period end |
| 2015-12-31 | $12.61M | -46.8% | 2017-03-29, Balance as of period end |
| 2014-12-31 | $23.71M | -2.2% | 2016-03-28, Balance as of period end |
| 2013-12-31 | $24.25M | -40.6% | 2015-03-30, Balance as of period end |
| 2012-12-31 | $40.84M | n/a | 2014-03-20, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | 2025-12-31 | $11.25M | -80.1% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | $8.22M | +357.5% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $4.59M | +24.9% |
| Lantern Pharma Inc. (LTRN) | 2025-12-31 | $4.50M | +2.7% |
| Decoy Therapeutics Inc. (DCOY) | 2025-12-31 | $5.17M | +241.9% |
| Mira Pharmaceuticals, Inc. (MIRA) | 2025-12-31 | $702.1K | -2.9% |
| Genprex, Inc. (GNPX) | 2025-12-31 | $2.20M | -12.3% |
| MetaVia Inc. (MTVA) | 2025-12-31 | $5.79M | -30.5% |
| Oragenics Inc (OGEN) | 2025-12-31 | $1.79M | +6.1% |
Compare TRAW, SHPH, LGVN, LTRN side by side · Screen every company in Pharmaceutical Preparations ↗